CLINICAL_TRIALS
trial_result
· 2021-02-02
Clinical Trial Update: Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis [Phase 2, Phase 3]
Summary
A Phase 2/3 trial assessing oral miltefosine plus topical paromomycin for American cutaneous leishmaniasis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fundacion Nacional de Dermatologia | Conditions: Cutaneous Leishmaniasis, American | Phase 2, Phase 3 | Status: COMPLETED